Chloroquine Prophylaxis for Health Care Workers at Risk for COVID
Sponsor: |
Columbia University |
Enrolling: |
Male and Female Patients |
Study Length: |
3 Months |
IRB Number: |
AAAS9992 |
U.S. Govt. ID: |
NCT04349371 |
Contact: |
Tommy Chen: 212-342-9051 / tkc2120@cumc.columbia.edu |
The purpose of this research study is to determine if chloroquine is effective in health care workers with moderate to high risk of exposure to COVID-19 in preventing symptomatic COVID-19 infections. The time frame for your involvement in the study is 3 months. During month 0, participants will be screened and randomized (like a flip of a coin) to a 3-month chloroquine versus an identical course of placebo. A placebo is a sugar pill which has no active ingredient. Participants will be followed by the investigator during months 1-3 either through in person visit or through telemedicine.
This study is closed
Investigator
Anca Askanase, MD, MPH
Are you 18 years of age or older? |
Yes |
No |
Are you employed by NewYork-Presbyterian Hospital? |
Yes |
No |
Does your work involve patient contact and possible exposure to COVID-19 at least 2 days/week for at least 8 hours/day? |
Yes |
No |
Are you already taking chloroquine for any other indications? |
Yes |
No |